ANGO
Angiodynamics IncCompany with tickers: ANGO
CIK
1275187
CUSIP
03475V101
Shares Outstanding
41,318,915
Website
https://www.angiodynamics.com
Investor Relations
https://www.angiodynamics.com/investors/
13F Activity (30d)
3 filings
2 filers
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Program Authorized
$15,000,000
as of 2024-07-16
Remaining Authorization
$13,300,000
as of 2026-02-28
Program Utilization
11.3%
$1,700,000 used of $15,000,000
Cash spent on buybacks by quarter
Cash deployed each quarter. Δ marks quarters derived from the company's cumulative year-to-date disclosures.
Repurchase History
| Fiscal Year Ended | Cash Spent | Source |
|---|---|---|
| 2026-02-28 YTD | $0 | 10-Q, filed 2026-04-02 |
| 2025-05-31 | $1,670,000 | 10-K, filed 2025-07-18 |
| 2024-05-31 | $0 | 10-K, filed 2025-07-18 |
| 2023-05-31 | $0 | 10-K, filed 2025-07-18 |
| 2019-05-31 | $0 | 10-K, filed 2019-07-25 |
| 2018-05-31 | $0 | 10-K, filed 2019-07-25 |
| 2017-05-31 | $13,557,000 | 10-K, filed 2019-07-25 |
| 2016-05-31 | $0 | 10-K, filed 2018-07-23 |
| 2015-05-31 | $0 | 10-K, filed 2017-08-04 |
| 2014-05-31 | $0 | 10-K, filed 2015-01-12 |
| 2013-05-31 | $0 | 10-K, filed 2015-01-12 |
| 2012-05-31 | $2,104,000 | 10-K, filed 2015-01-12 |